Virus Filtration Market Revenue Sales to Reach USD 7.0 Billion by 2026

21/lug/2020 10:42:20 Market Research News Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global virus filtration market size is expected to reach USD 7.0 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 12.7% during the forecast period. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.

Virus Filtration Market

Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/virus-filtration-market

Further key findings from the report suggest:

  • Consumables was the largest revenue generating segment in 2018 owing to the increased usage of consumables including reagents, kits, and membranes in biologics downstream processing
  • Chromatography technology segment is projected to expand at the fastest CAGR during the forecast period, owing to advancements such as disposable or single-use membranes that eliminate the risk of a potential virus contaminant
  • Biologicals segment held the largest market share in 2018 and is projected to maintain its dominance during the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
  • The biotechnology and biopharmaceutical companies segment is projected to expand at the fastest CAGR over the forecast period owing to increasing investment in R&D and production of biologics
  • North America led the virus filtration market in 2018 primarily due to the presence of several leading biotechnology companies and increased R&D activities
  • Asia Pacific is estimated to expand at the highest CAGR during the forecast period. Growing presence of CROs in countries including China and India due to the presence of a large genome pool, less stringent regulations, and availability of economical labor force is contributing to the regional growth
  • Some of the major players are Merck KGaA; Sartorius; Danaher; Thermo Fisher Scientific, Inc.; Charles River Laboratories International, Inc.; GE Healthcare; Asahi Kasei Medical Co., Ltd.; WuXi PharmaTech (Cayman) Inc.; Lonza; and Clean Cells

Grand View Research has segmented the global virus filtration market on the basis of product, technology, application, end use, and region:

Virus Filtration Product Outlook (Revenue, USD Million, 2015 - 2026)

  • Consumables
    • Kits and reagents
    • Others
  • Instruments
    • Filtration systems
    • Chromatography systems
  • Services

Virus Filtration Technology Outlook (Revenue, USD Million, 2015 - 2026)

  • Filtration
    • Consumables
    • Instruments
    • Services
  • Chromatography
    • Consumables
    • Instruments
    • Services

Virus Filtration Application Outlook (Revenue, USD Million, 2015 - 2026)

  • Biologicals
    • Vaccines and therapeutics
    • Blood and blood products
    • Cellular and gene therapy products
    • Tissue and tissue products
    • Stem cell products
  • Medical devices
  • Water purification
  • Air purification

Virus Filtration End Use Outlook (Revenue, USD Million, 2015 - 2026)

  • Biopharmaceutical & biotechnology companies
  • Contract research organizations
  • Medical devices companies
  • Academic institutes & research laboratories

Virus Filtration Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE

About Grand View Research

 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl